News & Features

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Programs to help maintain your physical and emotional wellness

January 05, 2022

Classes are designed to assist in symptom management and pain relief, as well as to help improve physical and emotional health.
Learn more

Novel immune cell population may trigger MS inflammation

December 17, 2021

The results of new study suggest that countering the activity of cells could be a new therapeutic approach for MS.
Learn more

Study suggests teriflunomide tempers lesion growth in children with MS

December 03, 2021

The findings suggest the medication might have beneficial effects in children with relapsing forms of MS.
Learn more

Researchers: Cold could alleviate MS symptoms

October 27, 2021

University of Geneva researchers wanted to know if they could divert the energy expended by the body when the immune system goes awry.
Learn more

New research suggests MS patients have robust T-cell responses to mRNA COVID-19 vaccines

September 20, 2021

The study measured both the antibody and T-cell responses in 20 patients with MS who were undergoing anti-CD20 treatment.
Learn more

Study: MS may affect survival rate after colorectal cancer diagnosis

September 17, 2021

The study found that people with MS were 45 percent more likely to die of any cause at six months after the cancer diagnosis than people without MS.
Learn more

NIH scientists build a cellular blueprint of MS lesions

September 14, 2021

According to the study’s authors, it’s possible that targeting C1q in human microglia could halt MS lesions in their tracks.
Learn more

Brain molecule helps cells that could spark remyelination

September 13, 2021

Researchers said the immunological nature of fractalkine could also be important for future drug development.
Learn more

Researchers examine extreme heat, multiple sclerosis link

August 09, 2021

The findings could guide region-specific strategies to manage MS, such as providing heat advisories and critical information on sudden changes in local weather to MS patients and healthcare providers.
Learn more

Programs to help maintain your physical and emotional wellness

January 05, 2022

Classes are designed to assist in symptom management and pain relief, as well as to help improve physical and emotional health.
Learn more

Novel immune cell population may trigger MS inflammation

December 17, 2021

The results of new study suggest that countering the activity of cells could be a new therapeutic approach for MS.
Learn more

Study suggests teriflunomide tempers lesion growth in children with MS

December 03, 2021

The findings suggest the medication might have beneficial effects in children with relapsing forms of MS.
Learn more

Researchers: Cold could alleviate MS symptoms

October 27, 2021

University of Geneva researchers wanted to know if they could divert the energy expended by the body when the immune system goes awry.
Learn more

New research suggests MS patients have robust T-cell responses to mRNA COVID-19 vaccines

September 20, 2021

The study measured both the antibody and T-cell responses in 20 patients with MS who were undergoing anti-CD20 treatment.
Learn more

Study: MS may affect survival rate after colorectal cancer diagnosis

September 17, 2021

The study found that people with MS were 45 percent more likely to die of any cause at six months after the cancer diagnosis than people without MS.
Learn more

NIH scientists build a cellular blueprint of MS lesions

September 14, 2021

According to the study’s authors, it’s possible that targeting C1q in human microglia could halt MS lesions in their tracks.
Learn more

Brain molecule helps cells that could spark remyelination

September 13, 2021

Researchers said the immunological nature of fractalkine could also be important for future drug development.
Learn more

Researchers examine extreme heat, multiple sclerosis link

August 09, 2021

The findings could guide region-specific strategies to manage MS, such as providing heat advisories and critical information on sudden changes in local weather to MS patients and healthcare providers.
Learn more

Study finds Wahls and Swank diets both reduce fatigue

August 06, 2021

Findings suggests the benefits of the dietary approaches are due to underlying mechanisms rather than unique characteristics of specific diets.
Learn more

Study: Disease comparisons offer clues to MS progression

July 21, 2021

New research shows the brain and spinal cord scars in people with multiple sclerosis may offer clues to why they develop progressive disability.
Learn more

Plant-based diet and a healthy microbiome may protect against MS

July 15, 2021

The study showed a diet rich in isoflavone protects against MS-like symptoms in a mouse model of the disease.
Learn more

Study suggests high-efficacy treatments reduce relapses in secondary progressive MS

July 09, 2021

A new study found that the more potent disease-modifying drugs are more effective in reducing flare-ups in secondary progressive MS than the less potent drugs that tend to be safer to take.
Learn more

Study suggests in many cases MS starts long before the diagnosis

June 28, 2021

Researchers found MS patients are often diagnosed years after their first demyelinating event.
Learn more

iConquerMS seeking participants for COVID-19 study

May 17, 2021

iConquerMS is conducting a study to answer questions on vaccine side effects, possible effects on MS symptoms, and how MS medications might influence vaccine.
Learn more

Study: Low levels of a simple sugar may be a MS biomarker

May 14, 2021

This opens up potential new avenues for identifying, at an early stage, which patients are at higher risk of progressive MS and adjusting their treatment accordingly.
Learn more

Social cognition plays a key role in everyday lives of people with MS

May 05, 2021

The study shows people with relapsing-remitting MS performed significantly lower in several social cognition areas, despite being classified as "cognitively normal."
Learn more

Verbal fluency deficits in MS may reflect impaired language ability

April 30, 2021

The findings suggest the need for more comprehensive neuropsychological testing among people with MS.
Learn more


Show More News